AssetMark Inc’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$663K Buy
3,401
+181
+6% +$37.5K ﹤0.01% 1169
2026
Q1
$723K Buy
3,220
+862
+37% +$215K ﹤0.01% 1094
2025
Q4
$568K Buy
2,358
+5
+0.2% +$1.28K ﹤0.01% 1113
2025
Q3
$644K Buy
2,353
+297
+14% +$81.1K ﹤0.01% 1055
2025
Q2
$531K Buy
2,056
+616
+43% +$147K ﹤0.01% 1037
2025
Q1
$322K Sell
1,440
-3
-0.2% -$700 ﹤0.01% 1059
2024
Q4
$330K Buy
1,443
+1,420
+6,174% +$342K ﹤0.01% 1017
2024
Q3
$5.66K Sell
23
-35
-60% -$7.82K ﹤0.01% 1715
2024
Q2
$11.1K Buy
58
+29
+100% +$5.88K ﹤0.01% 1480
2024
Q1
$5.74K Buy
29
+20
+222% +$3.67K ﹤0.01% 1445
2023
Q4
$1.55K Buy
+9
New +$1.38K ﹤0.01% 1571
2022
Q2
Sell
-6
Closed -$1K 1638
2022
Q1
$1K Buy
+6
New +$1.45K ﹤0.01% 1506
2018
Q4
Sell
-527
Closed -$61K 1520
2018
Q3
$61K Sell
527
-34
-6% -$3.72K ﹤0.01% 703
2018
Q2
$58K Sell
561
-56
-9% -$5.67K ﹤0.01% 692
2018
Q1
$61K Buy
617
+588
+2,028% +$55.6K ﹤0.01% 680
2017
Q4
$2K Buy
29
+24
+480% +$1.98K ﹤0.01% 1474
2017
Q3
$0 Buy
+5
New +$382 ﹤0.01% 1593
2017
Q1
Sell
-1
Closed 1406
2016
Q4
$0 Sell
1
-11
-92% -$674 ﹤0.01% 1361
2016
Q3
$1K Sell
12
-91
-88% -$6.06K ﹤0.01% 1180
2016
Q2
$7K Buy
+103
New +$6.07K ﹤0.01% 996
2016
Q1
Sell
-481
Closed -$26K 1370
2015
Q4
$26K Buy
+481
New +$27.1K ﹤0.01% 755

Other funds holding RMD

AssetMark Inc's RMD Position: Q2 2026 in Review

AssetMark Inc increased its ResMed (RMD) stake by 5.6% in Q2 2026, buying an estimated $37.5K and bringing the position to 3,401 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

AssetMark Inc first reported a position in RMD in Q4 2015 and has held it in 21 quarters since. The position peaked at $723K in Q1 2026. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • AssetMark Inc held 3,401 shares of ResMed worth $663K as of Q2 2026.
  • AssetMark Inc bought 181 ResMed shares in Q2 2026, an estimated $37.5K.
  • ResMed made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1169 holding.
  • AssetMark Inc first reported a position in ResMed in Q4 2015 and has held it in 21 quarters since.
  • AssetMark Inc's ResMed position peaked at $723K in Q1 2026.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.